Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Fenofibrate from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., updating the approved generic product.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.,)
FDA approved a supplemental application for Fenofibrate submitted by Cipla USA Inc.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for fenofibrate by Glenmark Pharmaceuticals Inc., USA under ANDA205566, resulting in updated labelin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Bostal LLC)
FDA approved a supplemental application for Fenofibrate (FENOFIBRATE) submitted by Bostal LLC under ANDA207805.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate submitted by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for fenofibrate from Ajanta Pharma USA Inc., indicating an approved change to the generic produc…
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Leading Pharma, LLC)
FDA approved a supplemental application for fenofibrate submitted by Leading Pharma, LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for fenofibrate.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for fenofibrate by Chartwell RX, LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for fenofibrate submitted by NorthStar RxLLC.
-
FDA approval · 2021-06-03FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Fenofibrate (ANDA 204019).
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fenofibrate from Alembic Pharmaceuticals Limited under an ANDA.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for fenofibrate submitted by Lupin Pharmaceuticals, Inc.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's supplemental application for fenofibrate (generic) under ANDA210782. The approval pertains to…
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for fenofibrate from Dr. Reddy's Laboratories, indicating an approved change to the product unde…
-
FDA approval · 2021-05-17FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for atorvastatin calcium by Accord Healthcare Inc., authorizing the continued commercialization of t…
-
FDA approval · 2021-05-14FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for fenofibrate (Amneal Pharmaceuticals NY LLC) under an ANDA.
-
FDA approval · 2021-05-14FDA Approved: FENOFIBRATE — Supplemental Application (Leading Pharma, LLC)
The FDA approved a supplemental application for fenofibrate submitted by Leading Pharma, LLC.
-
CLINICAL_TRIALS withdrawal · 2021-05-10Clinical Trial Update: Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia [Phase 3]
Phase 3 trial comparing NK-104-CR and Livalo IR in primary hyperlipidemia or mixed dyslipidemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-05-10Clinical Trial Update: Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia [Phase 3]
Phase 3 trial NK-104-CR for primary hyperlipidemia or mixed dyslipidemia was withdrawn.
-
FDA approval · 2021-05-04FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for atorvastatin calcium, authorizing the atorvastatin calcium product unde…
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: An Study Investigating Nic's Keto Diet on Cardiovascular Health in Healthy Adults With Mildly Elevated LDL Levels [NA]
Clinical trial assessing the effects of a ketogenic diet on cardiovascular health in healthy adults with mildly elevated LDL; study complete…